Gadobenate dimeglumine in MRI of acute myocardial infarction: Results of a phase III study comparing dynamic and delayed contrast enhanced magnetic resonance imaging with EKG, 201T1 SPECT, and echocardiography

Investigative Radiology

Volumn 37, Issue 3, 2002, Pages 135-145

  Cherryman, Graham R ^a   Pirovano, Gianpaolo ^a   Kirchin, Miles A ^a  

^a Bracco Imaging SpA   (Italy)

Author keywords

Contrast agent; Echocardiography; Gadobenate dimeglumine; MR imaging; Myocardial infarction; Thallium 201 SPECT

Indexed keywords

GADOBENATE DIMEGLUMINE; THALLIUM 201;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EQUIPMENT; FEMALE; HEADACHE; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASTE DISORDER; XEROSTOMIA;

EID: 0036119645     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200203000-00006     Document Type: Article

References (92)

1. The electrocardiographic diagnosis of acute myocardial infarction in the thrombolytic era
2. Correlation of post-mortem anatomic findings with electrocardiographic changes in patients with myocardial infarction: Retrospective study of patients with typical anterior and posterior infarcts
3. Electrocardiographic localization of coronary artery narrowings: Studies during myocardial ischemia and infarction in patients with one-vessel disease
4. Electrocardiographic and coronary arteriographic correlations during acute myocardial infarction
5. Cardiac MR imaging. Facts and fiction
6. MRI of myocardial infarction
7. Interim results of phase II clinical testing of gadobenate dimeglumine
8. Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA
9. Dynamic T1 measurement using snapshot-FLASH MRI
10. Gadolinium chelates with weak binding to serum proteins. A new class of high efficiency, general purpose contrast agents for magnetic resonance imaging
11. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology
12. Detection of intracranial metastases: A multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage
13. Alterations in TI of normal and reperfused infarcted myocardium after Gd-BOPTA versus Gd-DTPA on inversion recovery EPI
14. Sample size testing differences in proportions for paired-sample design
15. Snapshot FLASH MRI. Application to T1, T2, and chemical shift imaging
16. First-pass cardiac perfusion: Evaluation with ultrafast MR imaging
17. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction
18. Selection of noninvasive tests in the emergency room and in the coronary care unit
19. Myocardial imaging for the assessment of myocardial viability
20. Cross-sectional echocardiography in acute myocardial infarction: Detection and localization of regional left ventricular asynergy
21. Two-dimensional echocardiographic recognition of myocardial injury in man: Comparison with post-mortem studies
22. A review of statistical methods in the analysis of data arising from observer reliability studies
23. Characterisation of acute myocardial infarction by gated magnetic resonance imaging
24. Detection and characterisation of acute myocardial infarction in man with the use of gated magnetic resonance
25. Detection and localization of recent myocardial infarction by magnetic resonance imaging
26. Magnetic resonance imaging during acute myocardial infarction
27. Acute myocardial infarction: MR evaluation in 29 patients
28. Magnetic resonance imaging in patients with unstable angina: Comparisons with acute myocardial infarction and normals
29. Estimation of the functional and anatomic extent of myocardial infarction using magnetic resonance imaging
30. Nuclear magnetic resonance imaging of acute myocardial infarction within 24 hours of chest pain onset
31. Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging
32. Long-term follow-up of regional myocardial T2 relaxation times in patients with myocardial infarction evaluated with magnetic resonance imaging
33. Magnetic resonance imaging of myocardial infarction: Correlation with enzymatic, angiographic, and radionuclide findings
34. Characterization of acute myocardial infarction by magnetic resonance imaging
35. Value of magnetic resonance imaging in patients with a recent myocardial infarction: Comparison with planar thallium-201 scintigraphy
36. "Black blood" T2-weighted inversion-recovery MR imaging of the heart
37. Novel application of breath-hold turbo spin-echo T2 MRI for the detection of acute myocardial infarction
38. Magnetic resonance imaging of myocardial infarct
39. Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging
40. Subacute myocardial infarction: Assessment by STIR T2-weighted MR imaging in comparison to regional function
41. Acute myocardial ischemia: Magnetic resonance contrast enhancement with gadolinium-DTPA
42. TI magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA
43. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA
44. Magnetic resonance imaging of acute myocardial infarction: Gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion
45. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration
46. MR imaging of acute myocardial infarction: Value of Gd-DTPA
47. Reperfused and nonreperfused myocardial infarction: Diagnostic potential of Gd-DTPA-enhanced MR imaging
48. TI imaging of acute myocardial infarction by magnetic resonance tomography (MRT) using the paramagnetic relaxation substance gadolinium-DTPA
49. Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA
50. Improved detection of acute myocardial infarction by magnetic resonance imaging using gadolinium-DTPA
51. Myocardial infarct size after reperfusion therapy: Assessment with Gd-DTPA-enhanced MR imaging
52. Diagnostic significance of gadolinium-DTPA (diethylenetriamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic treatment for acute myocardial infarction: Its potential in assessing reperfusion
53. Gadolinium-enhanced magnetic resonance imaging in acute myocardial infarction
54. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis
55. Acute myocardial infarction: Comparison of T2-weighted and T1-weighted gadolinium-DTPA enhanced MR imaging
56. Acute, subacute, and chronic myocardial infarction: Quantitative analysis of gadolinium-enhanced MR images
57. Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size
58. Quantification of occlusive and reperfused myocardial infarct size with Gd-DTPA-enhanced MR imaging
59. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction
60. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction
61. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction
62. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction
63. Clinical value of delayed thallium-201 myocardial imaging in suspected acute myocardial infarction
64. Contrast-enhanced first pass myocardial perfusion imaging: Correlation between myocardial blood flow in dogs at rest and during hyperemia
65. Concepts of myocardial perfusion imaging in magnetic resonance imaging
66. Ischaemic heart disease: Assessment with gadolinium-enhanced ultrafast MR imaging and dypyridamole stress
67. Semiquantification of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging
68. MR first pass imaging: Quantitative assessment of transmural perfusion and collateral flow
69. Myocardial perfusion reserve: Assessment with multisection, quantitative, first-pass MR imaging
70. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution
71. Assessing myocardial perfusion in coronary artery disease with magnetic resonance first-pass imaging
72. Magnetic resonance first-pass myocardial perfusion imaging: Clinical validation and future applications
73. Magnetic resonance first-pass myocardial perfusion imaging
74. Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease; quantitative comparison with (201) Thallium-SPECT and coronary angiography
75. Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: Implications for transmural assessment of myocardial perfusion
76. Echo-planar magnetic resonance myocardial perfusion imaging: Parametric map analysis and comparison with Thallium SPECT
77. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging
78. Coronary artery disease: Combined stress MR imaging protocol-one-stop evaluation of myocardial perfusion and function
79. In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging
80. Myocardial perfusion modelling using MRI
81. Measurement of the arterial concentration of Gd-DTPA using MRI: A step toward quantitative perfusion imaging
82. Quantification of gadolinium-DTPA concentrations for different inversion times using an IR-turboFLASH sequence: A study on optimising multislice perfusion imaging
83. Capillary transfer constant of Gd-DTPA in the myocardium at rest and during vasodilation assessed by MRI
84. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: Standardized quantities and symbols
85. Validation of MRI myocardial perfusion in humans with PET
86. Safety assessment of gadobenate dimeglumine (Multihance): Extended clinical experience from phase I studies to post-marketing surveillance
87. An improved MR imaging technique for the visualization of myocardial infarction